SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors anticipate the upcoming 80th clinical event from the REGAL Phase 3 trial, fueling high-stakes buyout speculation and heavy short-covering momentum. The community is actively debating the trial's impact, the potential for a curative AML treatment, and the strategic interest from major pharmaceutical players.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a significant quantum computing breakthrough that demonstrates the ability to solve complex, classically intractable problems with high reliability. Investors are also digesting recent commentary from the CEO regarding the long-term potential of quantum value and the successful closing of business deferrals, fueling optimism that the stock remains undervalued after its recent sharp pullback.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing significant bearish pressure as investors react to a $600 million at-the-market equity offering, sparking concerns over share dilution. While some traders fear the impact of this offering on the stock price, others view the capital raise as a strategic necessity to support production capacity expansion amid robust industry demand.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the project's long-term utility against its ongoing price decline and frequent, short-lived volatility spikes. Community sentiment is deeply polarized, with some users accumulating tokens in anticipation of institutional adoption, while others condemn the project as a scam due to prolonged lack of price performance.

RF Acquisition Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 5, 2024, and is headquartered in Singapore.

RF Acquisition Corp II

RF Acquisition Corp II is seeing intense volatility and social media attention driven by its recent merger announcement with Nanyang Biologics, an AI-focused drug discovery firm. Investors are actively debating the stock's potential for a short squeeze, citing its low float and ongoing merger catalyst, while others warn of the inherent risks associated with high-volatility SPAC trading.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending as investors weigh an AI-focused debt financing deal against broader market skepticism and competitive pressures. The community remains divided, with many debating the sustainability of AI-driven capital expenditures while others view current price levels as a favorable entry point heading into earnings.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Investors are closely monitoring the Federal Reserve's path forward and the impact of the Middle East conflict on oil prices, while ongoing community debate persists over the market's resilience despite high debt levels. Sentiment remains mixed as traders weigh the potential for a tech-led market correction against bullish momentum driven by AI infrastructure spending.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to positive sentiment across the biotech sector, alongside strong community discussion regarding the potential commercial value of their oncology platform and upcoming regulatory catalysts. The discourse is heavily focused on the company's progress toward its prostate cancer BLA submission and speculation surrounding potential acquisition interest from major pharmaceutical players.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is seeing increased investor attention as community members analyze its oversold RSI levels and strong fundamentals, though bearish sentiment persists regarding regulatory headwinds and broader Chinese market volatility. Speculation is high about potential future stimulus measures and the company's long-term pivot toward AI and robotics.

Daily surprises, near and far. Your source for travel inspiration and more. Travel moves you!

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending following reports that the U.S. Department of Justice has cleared its $110 billion merger with Paramount Skydance, a major milestone that has the community debating the deal's future amid potential legal challenges from state attorneys general. While some investors view the regulatory green light as a path toward closing, others remain focused on ongoing antitrust hurdles and the long-term debt implications of the combined entity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NTSK I see a growing company especially in this era of new tech …new Ai …cybersecurity etc 
I’m in. They can post what they want ..the analysts can say they don’t make enough …they failed but I see it differently. I’m holding for a much higher price. 
Netskope … a household name/business necessity.

StockTwits for iOS

Netskope Inc. - Ordinary Shares - Class A

 I see a growing company especially in this era of new tech …new Ai …cybersecurity etc 
I’m in. They can post what they want ..the analysts can say they don’t make enough …they failed but I see it differently. I’m holding for a much higher price. 
Netskope … a household name/business necessity.